A detailed history of Creative Planning transactions in Opko Health, Inc. stock. As of the latest transaction made, Creative Planning holds 26,924 shares of OPK stock, worth $44,155. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,924
Previous 31,486 14.49%
Holding current value
$44,155
Previous $39,000 2.56%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$1.21 - $1.68 $5,520 - $7,664
-4,562 Reduced 14.49%
26,924 $40,000
Q2 2024

Aug 15, 2024

BUY
$1.21 - $1.42 $9,407 - $11,040
7,775 Added 32.79%
31,486 $39,000
Q1 2024

May 10, 2024

SELL
$0.87 - $1.57 $3,092 - $5,581
-3,555 Reduced 13.04%
23,711 $28,000
Q4 2023

Feb 14, 2024

SELL
$1.23 - $1.63 $87,919 - $116,510
-71,479 Reduced 72.39%
27,266 $41,000
Q2 2023

Jul 21, 2023

SELL
$1.37 - $2.17 $1,856 - $2,940
-1,355 Reduced 1.35%
98,745 $214,000
Q1 2023

May 15, 2023

BUY
$1.06 - $1.61 $2,191 - $3,327
2,067 Added 2.11%
100,100 $146,000
Q4 2022

Feb 10, 2023

BUY
$1.05 - $2.01 $3,502 - $6,705
3,336 Added 3.52%
98,033 $122,000
Q3 2022

Nov 03, 2022

BUY
$1.81 - $2.81 $9,931 - $15,418
5,487 Added 6.15%
94,697 $179,000
Q2 2022

Aug 15, 2022

BUY
$2.33 - $3.61 $9,233 - $14,306
3,963 Added 4.65%
89,210 $226,000
Q1 2022

May 16, 2022

SELL
$2.87 - $4.93 $855 - $1,469
-298 Reduced 0.35%
85,247 $293,000
Q4 2021

Feb 11, 2022

SELL
$3.52 - $5.15 $429 - $628
-122 Reduced 0.14%
85,545 $411,000
Q3 2021

Nov 10, 2021

BUY
$3.44 - $4.24 $18,139 - $22,357
5,273 Added 6.56%
85,667 $313,000
Q2 2021

Aug 04, 2021

SELL
$3.33 - $4.55 $58,761 - $80,289
-17,646 Reduced 18.0%
80,394 $326,000
Q1 2021

Apr 30, 2021

BUY
$4.19 - $5.99 $231,531 - $330,995
55,258 Added 129.16%
98,040 $421,000
Q4 2020

Jan 29, 2021

BUY
$3.27 - $4.87 $9,404 - $14,006
2,876 Added 7.21%
42,782 $169,000
Q3 2020

Nov 05, 2020

SELL
$2.99 - $5.96 $348,012 - $693,696
-116,392 Reduced 74.47%
39,906 $147,000
Q2 2020

Jul 23, 2020

BUY
$1.15 - $3.41 $142,424 - $422,318
123,847 Added 381.64%
156,298 $533,000
Q1 2020

May 05, 2020

SELL
$1.34 - $2.32 $12,060 - $20,880
-9,000 Reduced 21.71%
32,451 $43,000
Q4 2019

Jan 30, 2020

SELL
$1.42 - $2.17 $4,586 - $7,009
-3,230 Reduced 7.23%
41,451 $61,000
Q2 2019

Jul 26, 2019

SELL
$1.79 - $2.61 $6,154 - $8,973
-3,438 Reduced 7.14%
44,681 $109,000
Q1 2019

Apr 24, 2019

SELL
$2.42 - $3.83 $3,146 - $4,979
-1,300 Reduced 2.63%
48,119 $126,000
Q4 2018

Feb 12, 2019

SELL
$2.46 - $3.87 $163,565 - $257,316
-66,490 Reduced 57.36%
49,419 $149,000
Q4 2018

Feb 01, 2019

SELL
$2.46 - $3.87 $984 - $1,548
-400 Reduced 0.34%
115,909 $349,000
Q3 2018

Oct 25, 2018

BUY
$3.29 - $6.29 $16,450 - $31,450
5,000 Added 4.49%
116,309 $402,000
Q2 2018

Jul 20, 2018

SELL
$2.99 - $4.99 $5,450 - $9,096
-1,823 Reduced 1.61%
111,309 $523,000
Q1 2018

Apr 18, 2018

SELL
$3.11 - $5.12 $2,643 - $4,352
-850 Reduced 0.75%
113,132 $359,000
Q4 2017

Jan 17, 2018

SELL
$4.61 - $7.04 $225,714 - $344,692
-48,962 Reduced 30.05%
113,982 $559,000
Q3 2017

Oct 17, 2017

BUY
$5.88 - $7.11 $958,110 - $1.16 Million
162,944
162,944 $1.12 Million

Others Institutions Holding OPK

About OPKO HEALTH, INC.


  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $1.27B
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.